Bormioli Pharma, an international manufacturer of pharmaceutical packaging and medical devices, recently announced an increase of 47% in its North American sales for 2023.   This notable growth is a direct result of the company’s rapidly evolving infrastructure and expanded capacity, tailored to meet the demands of the North American pharmaceutical market, including an increased need for pharmaceutical glass vials.   Bormioli Pharma strengthened its strategic focus on the US market fou...